Bolus iron dosing may up infection, death risk in dialysis patients

06/21/2013 | HealthDay News

Researchers looked at data from more than 117,000 kidney dialysis patients and found that those who received large doses of intravenous iron over a short period of time were more likely to develop serious infections and suffer infection-related death than those who received maintenance dosing. The risks were especially high for patients who used a catheter or who had recently had an infection. The findings appear online in the Journal of the American Society of Nephrology.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC